Miltefosine to Treat Mucocutaneous Leishmaniasis

Clinical trial NCT01050907 · COMPLETED

Trial details

NCT number: NCT01050907
Sponsor: Knight Therapeutics (USA) Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mucosal Leishmaniasis Cutaneous Leishmaniasis

Start date: 2010-05-01
Primary completion: 2015-02-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.